Saad Mark E
Insider CIK 1295913 · CYTX Chief Financial Officer · AXSM Director · RMED Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2026-06-08 | 2026-06-10 | 1,429 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2026-06-08 | 2026-06-10 | 1,429 | — | $0 | 11,431 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2026-06-05 | 2026-06-09 | 1,721 | — | $0 | 1,721 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-12-31 | 2026-01-02 | 31,346 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-12-31 | 2026-01-02 | 6,231 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-12-31 | 2026-01-02 | 31,346 | $4.95 | $155.2K | 41,348 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-12-31 | 2026-01-02 | 31,346 | $165.18 | $5.18M | 10,002 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-12-31 | 2026-01-02 | 6,231 | $165.18 | $1.03M | 10,002 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-12-31 | 2026-01-02 | 6,231 | $8.02 | $50.0K | 16,233 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2025-09-05 | 2025-09-05 | 9,127 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2025-09-05 | 2025-09-05 | 9,127 | $9.00 | $82.1K | 19,129 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2025-09-05 | 2025-09-05 | 9,127 | $125.07 | $1.14M | 10,002 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-06-06 | 2025-06-10 | 3,166 | — | $0 | 3,166 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-06-06 | 2025-06-10 | 1,429 | — | $0 | 1,429 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2025-02-21 | 2025-02-25 | 1,494 | — | $0 | 1,494 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise deriv | 2024-09-11 | 2024-09-11 | 11,016 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | M Exercise | 2024-09-11 | 2024-09-11 | 11,016 | $3.67 | $40.4K | 21,018 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | S Sale | 2024-09-11 | 2024-09-11 | 11,016 | $91.31 | $1.01M | 10,002 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2024-06-07 | 2024-06-11 | 5,799 | — | $0 | 5,799 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2024-02-27 | 2024-02-29 | 1,519 | — | $0 | 1,519 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2023-06-02 | 2023-06-06 | 5,681 | — | $0 | 5,681 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2023-03-02 | 2023-03-06 | 2,224 | — | $0 | 2,224 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2022-06-03 | 2022-06-07 | 16,976 | — | $0 | 16,976 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2022-03-04 | 2022-03-08 | 2,337 | — | $0 | 2,337 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2021-11-17 | 2021-11-19 | 100 | $34.40 | $3.4K | 100 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2021-11-17 | 2021-11-19 | 3,000 | $34.53 | $103.6K | 10,002 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2021-11-17 | 2021-11-19 | 100 | $34.40 | $3.4K | 100 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2021-11-17 | 2021-11-19 | 100 | $34.45 | $3.4K | 100 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-06-04 | 2021-06-08 | 7,325 | — | $0 | 7,325 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2021-03-05 | 2021-03-09 | 1,241 | — | $0 | 1,241 | SEC↗ |
| RMED Ra Medical Systems, Inc. | A Award | 2021-01-05 | 2021-01-07 | 8,227 | — | $0 | 13,750 | SEC↗ |
| RMED Ra Medical Systems, Inc. | A Award | 2020-10-12 | 2020-10-14 | 100,000 | — | $0 | 138,085 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-06-05 | 2020-06-05 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2020-03-17 | 2020-03-19 | 3,789 | — | $0 | 3,789 | SEC↗ |
| RMED Ra Medical Systems, Inc. | A Award deriv | 2020-01-06 | 2020-01-08 | 49,576 | — | $0 | 49,576 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2019-06-07 | 2019-06-10 | 13,000 | — | $0 | 13,000 | SEC↗ |
| RMED Ra Medical Systems, Inc. | A Award | 2019-06-06 | 2019-06-07 | 29,850 | — | $0 | 38,085 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | P Buy | 2019-05-23 | 2019-05-24 | 3,500 | $22.33 | $78.2K | 7,002 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2019-03-19 | 2019-03-21 | 29,387 | — | $0 | 29,387 | SEC↗ |
| RMED Ra Medical Systems, Inc. | A Award | 2018-10-04 | 2018-10-05 | 8,235 | — | $0 | 8,235 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2018-06-01 | 2018-06-05 | 13,000 | — | $0 | 13,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2018-03-12 | 2018-04-05 | 32,602 | — | $0 | 32,602 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2017-03-15 | 2017-03-17 | 31,346 | — | $0 | 31,346 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2017-03-15 | 2017-03-17 | 11,000 | — | $0 | 11,000 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2016-05-27 | 2016-06-01 | 6,231 | — | $0 | 6,231 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2015-11-24 | 2015-11-24 | 3,502 | — | $0 | 0 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | C Conversion | 2015-11-24 | 2015-11-24 | 3,502 | $5.94 | $20.8K | 3,502 | SEC↗ |
| AXSM Axsome Therapeutics, Inc. | A Award deriv | 2015-11-19 | 2015-11-23 | 9,127 | — | $0 | 9,127 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2014-04-11 | 2014-04-15 | 170,000 | — | $0 | 1,090,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2013-01-31 | 2013-02-04 | 75,000 | — | $0 | 920,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2013-01-31 | 2013-02-04 | 150,000 | — | $0 | 845,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | D To issuer | 2013-01-31 | 2013-02-04 | 14,070 | — | $0 | 138,430 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | P Buy | 2012-03-14 | 2012-03-14 | 9,400 | $2.55 | $24.0K | 151,900 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | P Buy | 2012-03-14 | 2012-03-14 | 600 | $2.54 | $1.5K | 152,500 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award deriv | 2012-01-26 | 2012-01-30 | 40,000 | — | $0 | 695,000 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award | 2012-01-26 | 2012-01-30 | 33,500 | — | $0 | 122,500 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | A Award | 2012-01-26 | 2012-01-30 | 20,000 | — | $0 | 142,500 | SEC↗ |
| CYTX CYTORI THERAPEUTICS, INC. | D To issuer | 2012-01-26 | 2012-01-30 | 33,500 | — | $0 | 89,000 | SEC↗ |